Decreased levels of soluble fractalkine as an early biomarker distinguishing secondary progressive from relapsing remitting multiple sclerosis.

İrkeç C., Kuz T., Fidan I.

4th International Turkic World Congress of Multiple Sclerosis, Abstracts and Full Texts Book, cilt.4, ss.24-26, 2022 (Düzenli olarak gerçekleştirilen hakemli kongrenin bildiri kitabı)